Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
PBYIPuma Biotechnology, Inc.
| Figure | PBYIPuma Biotechnology, Inc.FY2025 · Dec |
|---|---|
| Revenue | $228.37M |
| Revenue, yoy | −0.9% |
| Net income | $31.11M |
| Net income, yoy | +2.8% |
| Net margin | 13.6% |
| Free cash flow | $41.73M |
| FCF margin | 18.3% |
| EPS, diluted | $0.61 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed